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BACKGROUND 
The subjective nature of the experience of chronic breathlessness (dyspnoea) creates 
challenges for patients who need to communicate its intensity, and for clinicians and 
researchers who need to measure the symptom in order to plan management and assess the 
effect of interventions.  
 
The numerical rating scale (NRS) [1] and modified Borg scale (mBorg) [2] are recommended 
measures for breathlessness. [3] However, their use has extended beyond their initial 
validation. NRS scales using different time frames (“now” and “average”) have been 
validated,[1, 4, 5] but not for the mBorg. Further, participants might have a preference for 
mBorg scores with associated verbal descriptors.  
 
Objectives: To investigate whether: i) there is a response bias against using mBorg numerical 
ratings that lack categorical labels , ii) the timeframe (average/24 hours, “worst”, “now” or 
“at rest”) of the mBorg or NRS effects participants’ assessment, iii) mBorg and NRS scores 
are correlated  
 
METHODS 
This was a secondary analysis of pooled data from 1,048 participants (510 men, 396 women, 
142 gender data unavailable: diagnoses: cancer 223 [21.3%], heart failure 200 [19%], non-
malignant lung disease 617 [59%]) with breathlessness due to a variety of causes from 10 
studies of people where mBorg, at least, was measured. Where both mBorg and NRS were 
measured, these were concurrent. All studies used the same version of the Borg; a variant of 
the Borg Category-Ratio scale with a maximum value of 10, and with verbal descriptors 
missing for values 6 and 8.  
Most contributing studies are described more fully elsewhere[7-14] but are summarised here 
as follows: i) quantifiable data from a primarily qualitative study (study 1. N=47; mean age 
69 (range 46-92); measures mBorg (average 24hrs, worst, rest, non-specific now, exertion) 
with NRS for 7 participants[8] ii) two phase III trials (study 2. N=35; mean age 70 (41-89); 
measures mBorg and NRS (average 24hrs, worst, rest, non-specific now, exertion)][10]: 
study 3. N = 154; mean age 71 (28-91); measures mBorg and NRS (rest, exertion)[12]:) iii) 
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two feasibility studies, (study 4. N=46; mean age 69.5 (62-73) measures mBorg and NRS 
(rest)[7]: study 5. N=13; mean age 67 (53-80); measures mBorg only (rest, exertion)[13] iv)  
five observational (study 6. N = 50; mean age 69 (42-83); measures mBorg only (pre and post 
exertion)][9]: study 7. N = 109; mean age 65 (38-52); measures mBorg only (now)[11]: study 
8. N = 99; measures mBorg only (average over previous 24 hours) [personal communication, 
unpublished data]: study 9. N = 353; mean age 65 (24-90); measures mBorg only (average 
and worst over previous 24 hours)[14]: study 10. N = 142; mean age 69 (34-91); measures 
mBorg and NRS (average, worst over past 24 hours, now) [personal communication, 
unpublished data]) Proxy scores were excluded.  
The individual distributions of mBorgs and NRSs (average, worst, now, rest, exertion) were 
visualized with predicted values using truncated Poisson distribution with their corresponding 
mean plotted as a reference. Descriptive statistics including mean, standard deviation, and 
frequency were examined. The strength of association between mBorgs and corresponding 
NRSs was examined using two-way mixed intraclass correlation (consistency).  
 
RESULTS  
 
The following measures were available for analysis: i) mBorg; The frequency of scores for 
numbers 6 and 8 (no verbal descriptor) was less than expected. There were also fewer than 
expected measures for 0.5 (verbal descriptor of “Very very weak [just noticeable)]”). 
In general, scores for average/24 hours were normally distributed for mBorg (other than the 
pattern noted above) and NRS. However, no NRS “average” scores exceeded 8. Although an 
NRS score of 7 is considered “severe”, equivalent to an mBorg of 5, mBorg “average” scores 
included the maximum of 10. (see Figure 1) 
The pattern of scores for NRS and mBorg “worst”/24 hours was similar although, as expected 
given the equivalent severity scores, there were more high NRS scores. 
For point in time measures the patterns for mBorg and NRS “exertion” were similar, with few 
mild scores.  Conversely mBorg “at rest”, “now”, and NRS “at rest” scores shared a similar 
pattern but with very few severe scores. However the NRS “now” had measures across the 
response spectrum, including very severe scores. 
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The strongest association between NRS (N=21; mean 7.23 [1.80]) and mBorg (N=261; mean 
5.55 [2.18]) was for “on exertion” (ICC=0.66, 95% CI 0.33, 0.85); the weakest for “now” 
(NRS=106, mean 4.51[2.72]; MBorg N=368, mean 2.36[1.79]; ICC= 0.14, ─0.05, 0.33). 
Others were: “average” 0.51, (0.15, 0.75); “worst” 0.55, (0.34, 0.71)and “rest” 0.33 (─0.09, 
0.66).  
 
 
DISCUSSION 
Our data indicate preferential reporting of mBorg scores with descriptors. This may be due to 
the mBorg’s stem question: “Choose a number whose words best describe…”. A less than 
predicted use of 0.5, despite a descriptor, suggests that “very very weak” is either 
indistinguishable in the context of chronic breathlessness or “0.5” is not understood; the VAS 
may be more sensitive at reporting breathlessness due to light intensity work.[15]  
Apart from the observed reduction in non-descriptor mBorg scores, the pattern of mBorg and 
NRS scores in relation to the previous 24 hours appears to be as expected apart from a 
possible ceiling with the NRS.  
The observed pattern of responses for NRS “now” likely reflects the contemporaneous 
context. For example a patient waiting in the clinic room for some time will respond 
differently to one who has hurried into clinic. Thus, unless the measure is taken with close 
definition of the circumstances of “now”, responses will be difficult to interpret.   
Despite the numerical discrepancy between the two scales, the intracluster correlations were 
moderate for “on exertion”, and “average”, albeit with wide confidence intervals, suggesting 
that the mBorg might be used to assess intensity of breathlessness on average/past 24 hours. 
The mBorg and NRS “now” were poorly correlated, presumably for the reasons above.  It 
should be noted that with some ICC calculations there is a large discrepancy between the 
smaller and larger n. Therefore, the ICCs should be interpreted with caution because the 
missing data cannot be assumed to be missing at random. 
Implications for clinical studies 
These data suggest that there is a participant response bias against using numerical ratings 
that lack categorical labels, in which case, the scale would ‘lose’ the ratio properties that 
5 
 
Borg wanted to preserve. Therefore we recommend that given the non-controlled conditions 
in chronic breathlessness clinical studies, the NRS is used. Reported mBorg values may differ 
if the stem is simplified to “choose a number to describe…”.  
The NRS “at rest” and “on exertion”, appear useful as “point in time” measures. However, 
the circumstances of “now” should be stipulated. Given the possible ceiling for “average” 
NRS scores, notwithstanding the issue above, the mBorg (average/24 hours) may be 
preferable in populations with severe daily breathlessness. 
 
CONCLUSIONS 
The analysis of this pooled data from people with chronic breathlessness suggests that there is 
a response bias in favour of mBorg responses with a verbal descriptor. The theoretical 
advantages of the mBorg scale under known and scalable stimulus conditions (e.g., in 
pulmonary rehabilitation programs or cardiopulmonary exercise testing) therefore are not 
necessarily maintained in less-controlled clinical studies. A change in mBorg stem question 
should be considered and tested. The NRS scale should be used in preference, except for 
people with very severe breathlessness. The context of “point in time” measures should be 
clearly stated on measure-completion. 
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Figure 1.  MBorg and NRS scores in relation to perception of breathlessness over the 
past 24 hours and scores measured now, at rest or on exertion. Histograms with 
predicted truncated Poisson probabilities. Average scores (MBorg N = 498; NRS  N = 
86); Worst scores (MBorg N = 559; NRS N = 106); Now (MBorg N = 368; NRS N= 108); 
rest (MBorg N = 261; NRS N = 60); exertion (MBorg N = 261 , NRS N =23). 
 
 
